Breast Center at Moores UCSD Cancer Center Receives National Accreditation

 

July 28, 2009  |  

The Breast Center at the Moores UCSD Cancer Center has received accreditation from the National Accreditation Program of Breast Centers (NAPBC), a program administered by the American College of Surgeons. The Breast Center at the Moores UCSD Cancer Center is the first hospital-based program in California to receive this accreditation.

According to the NAPBC, this recognition – which is for three years and is considered “full accreditation” – is given only to those centers that “provide the highest level of quality breast care and that undergo a rigorous evaluation process and review of their performance.”

The NAPBC review includes such areas as leadership, clinical management, research, community outreach, professional education and quality improvement. In all, the Cancer Center’s Breast Center met all 27 standards set by the NAPBC.

“The accreditation from such an important organization only underscores the high level of expertise and commitment from our doctors, nurses and staff at the Moores Cancer Center,” said Anne Wallace, MD, professor of clinical surgery at the UC San Diego School of Medicine and Director of the Breast Center at the Moores UCSD Cancer Center. “All of us share in this recognition.”

“It’s an extraordinary honor to be recognized by a national medical organization for our exceptional work and continued dedication to our patients,” said Barbara Parker, MD, professor of clinical medicine at the UC San Diego School of Medicine and medical director of oncology services at the Moores UCSD Cancer Center.

The NAPBC is a consortium of professional organizations dedicated to improving quality of care and monitoring outcomes of patients with breast disease and breast cancer.

The UCSD Moores Cancer Center is one of the nation’s 40 National Cancer Institute-designated Comprehensive Cancer Centers, combining research, clinical care and community outreach to advance the prevention, treatment and cure of cancer.

# # #

Media Contact: Steve Benowitz, 619-543-6163, sbenowitz@ucsd.edu




Media Contact

Share This Article


Related News

5/26/2017
In a small, randomized Phase I/II clinical trial (SAT1), researchers at University of California San Diego School of Medicine say a 100-year-old drug called suramin, originally developed to treat Afri ...
5/22/2017
On Sunday, May 21, the Student Run Free Clinic Project at UC San Diego was recognized by the American Psychiatric Association (APA) for excellence in caring for the community. For two decades, the Stu ...
5/22/2017
Liver cirrhosis is the 12th leading cause of mortality worldwide and approximately half of those deaths are due to alcohol abuse. Yet apart from alcohol abstinence, there are no specific treatments to ...
5/21/2017
Among 12- to 17-year-olds who have never used tobacco products, nearly half were considered receptive to tobacco marketing if they were able to recall or liked at least one advertisement, report resea ...



Follow Us